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Set2 (KMT3)-dependent methylation (me) of histone H3 at lysine 36 (H3K36) promotes deacetylation of
transcribed chromatin and represses cryptic promoters within genes. Although Set2 is the only methyltrans-
ferase (KMTase) for H3K36 in yeast, it is not known if Set2 is regulated or whether the different methylation
states at H3K36 are functionally distinct. Here we show that the N-terminal 261 residues of Set2 (Set21-261),
containing the SET KMTase domain, are sufficient for H3K36me2, histone deacetylation, and repression of
cryptic promoters at STE11. Set2-catalyzed H3K36me2 does not require either Ctk1-dependent phosphoryla-
tion of RNA polymerase II (RNAPII) or the presence of the phospho–C-terminal domain (CTD) interaction
(SRI) domain of Set2. This finding is consistent with a known correlation between H3K36me2 and whether a
gene is on or off, but not the level of activity of a gene. By contrast, H3K36me3 requires Spt6, proline 38 on
histone H3 (H3P38), the CTD of RNAPII, Ctk1, and the C-terminal SRI domain of Set2. We suggest that the
C-terminal region of Set2, in conjunction with the phosphorylated CTD of RNAPII, influences the KMTase
activity to promote H3K36me3 during transcription elongation.
The packaging of DNA into chromatin plays an important
role in the fidelity of DNA-related processes. The position of
nucleosomes, covalent histone modifications, and the integrity
of individual histone proteins all contribute to the accessibility
and function of DNA. Histones and their modifications influ-
ence the expression of genes both positively and negatively and
act at the initiation, elongation, and termination stages of tran-
scription.
One such modification, methylation of lysine 36 on histone
H3 (H3K36), catalyzed by the Set2 histone methyltransferase
(KMT3), is associated with the elongation phase of transcrip-
tion and is found within the coding regions of actively tran-
scribed genes (19, 24, 25, 39, 41, 42, 46). Set2 catalyzes all three
states of methylation at H3K36, monomethyl (me1), dimethyl
(me2), and trimethyl (me3), and negatively influences gene
expression (20), including the repression of cryptic promoters
within the coding region of genes such as STE11 (5, 11, 23).
Repression is proposed to result from recruitment of the
Rpd3S histone deacetylase complex to specific modifications
on the chromatin, including an interaction between methylated
H3K36 and the chromodomain of Eaf3, leading to deacetyla-
tion and stabilization of newly transcribed chromatin, particu-
larly on poorly expressed genes (5, 11, 15, 22, 23). The pres-
ence of H3K36me2 correlates with whether a gene is expressed
or not (39), while H3K36me3 tends to correlate with highly
expressed genes (38), supporting distinct functions for the two
modifications.
Analysis of the C-terminal SRI domain of Set2 indicates that
it interacts with the phosphorylated carboxy-terminal domain
(CTD) of Rbp1(26, 45), the largest subunit of RNA polymer-
ase II (RNAPII), and is required for normal levels of
H3K36me (16). This interaction supports cotranscriptional
deposition of methyl groups on H3K36 during transcription
elongation. Further support for H3K36 methylation being a
cotranscriptional modification comes from observations that
Ctk1, a subunit of a cyclin-dependent kinase complex (CTD-K)
that acts on the CTD of Rbp1 within RNAPII (6, 21, 36, 46),
and Spt6, a transcription elongation factor (4, 9, 10, 14), are
required for H3K36 methylation (8, 15, 19, 47) and for repres-
sion of the cryptic promoters at STE11 (5).
Spt6 is an essential protein that binds to histone H3 and is
capable of nucleosome assembly in vitro (4). Spt6 is known to
control the initiation (1), elongation (10, 13, 14, 18, 27), and
termination (12) phases of transcription, including cotranscrip-
tional pre-mRNA processing and export (48). The protein has
several domains, including an EF hand, a resolvase domain, a
helix-hairpin-helix DNA binding domain, and an SH2 domain.
The SH2 domain of mammalian Spt6 binds to the CTD on
RNAPII when phosphorylated at Ser2 (48). In Saccharomyces
cerevisiae, the requirement for Spt6 in maintaining H3K36
methylation is allele specific (8). Strains expressing the spt6-
140 allele show normal levels of H3K36 methylation, while
those expressing the spt6-1004 allele show defects in H3K36
dimethylation and trimethylation.
At present it is not known if the different methylation states
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at H3K36 are associated with different functions, although
there are functions associated with Set2 that are likely to be
independent of the Rpd3S complex and cotranscriptional his-
tone deacetylation (3, 43, 44). Moreover, it is not known if Set2
KMTase activity is regulated in any way. Here we show that the
region of Set2 (1-261) containing the SET domain is sufficient
for H3K36me2, histone deacetylation, and repression of cryp-
tic promoters at STE11 but not for H3K36me3. Moreover,
Set2-catalyzed H3K36me2 is largely independent of Ctk1-de-
pendent CTD phosphorylation and the SRI domain of Set2,
consistent with the observations that H3K36me2 correlates
with whether a gene is “on” or “off,” but not the level of activity
of a gene (39). By contrast, H3K36me3 requires the integrity of
H3P38, Spt6, the CTD of RNAPII, Ctk1, and the SRI domain
of Set2. These data indicate that the different methylation
states created by the Set2 KMTase are likely to be regulated
and are functionally distinct.
MATERIALS AND METHODS
Strains used in this study are as follows: two strains based on the BY4741
genetic background (Euroscarf) (a set2 strain and a ctk1 strain); OY 51, 56,
57, and 58 {MAT his4-912 lys2-128 suc2uas(1900/390) his3200 ura3-52
leu2 rpb1187::HIS3 [RPB1 rpb1104 rpb1103 (or rpb1101) URA3 CEN]} (33)
(CTD truncations); WZY42 (49) (H3P38V); and FY2181 (MATa leu21 his4-912
lys2-128 SPT6/FLAG) (ctk1) and its derivative FY2180 (MATa leu21 his4-912
lys2-128 spt6-1004/FLAG) or FY119 (MAT his4-912 lys2-128 leu2 1 ura3-52
trp1-63) (Spt6 truncation). Truncations and tagging of Set2 were carried out as
described previously (16, 46). FLAG-tagged SET2 and truncated derivatives
were expressed from the SET2 genomic locus or from the ADH1 promoter in
plasmid PN823 (32). Other strains, including epitope-tagged derivatives, trunca-
tions, and gene deletions, were constructed by single-step gene replacement
using PCR-generated DNA fragments (29). The truncation of Spt6 (Spt6C) was
constructed in the genomic locus by replacing the last 606 bases (202 amino
acids) with a TGA stop codon and the ADH1 terminator. As a control the stop
codon of wild-type (WT) Spt6 was replaced with a TGA codon followed by the
ADH1 terminator. Appropriate targeting of disruption cassettes was confirmed
by PCR and, in case of double mutants, by mating single mutant haploids and
basic genetic analysis after sporulation and tetrad dissection. Epitope tagging was
confirmed by Western blotting. For Northern blotting, chromatin immunopre-
cipitation (ChIP) experiments, and chromatin preparation, strains were grown in
yeast extract-peptone-dextrose (YPD; glucose), YPR (raffinose), or YPG (ga-
lactose) medium at 30°C to exponential phase (approximately 1  107 to 1.5 
107 cells/ml). The sequences of all primers used in this work are available on
request.
RNA preparation and Northern blotting. Total RNA was prepared by hot
acid-phenol extraction and separated on 1.5% formaldehyde–morpholinepro-
panesulfonic acid–agarose gels for 5 h in FA buffer, blotted onto nylon. Fixed
RNA was sequentially hybridized to radiolabeled probes overnight at 64°C in 2
SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate). Membranes were
washed four times for 15 min in 0.1 SSC–0.1% sodium dodecyl sulfate (SDS)
at room temperature (twice) and then at 64°C (twice). Bands were detected by
autoradiography.
Generation of antiserum specific for Set2. Bacterially expressed, recombinant
Set2 containing N-terminal amino acids 1 to 261 was prepared using induction
and purification procedures as previously described (42). This N-terminal Set2
fragment was emulsified in Freund’s complete adjuvant and injected into rabbits
following the protocol and procedures from Covance, Inc. The resulting blood
samples from several injected rabbits were screened for specificity to Set2 via
Western blot analysis of yeast wild-type and set2 whole-cell extracts. Antisera
were compared to the matched preimmune serum for each rabbit as a control,
and the blood sample of highest antibody avidity was selected. Data indicate
that the antiserum recognizes a major epitope at the C-terminal region of
Set2. Thus, epitope tagging was necessary to detect the C-terminally trun-
cated versions of Set2.
Coimmunoprecipitation. Coimmunoprecipitation experiments were per-
formed essentially as previously described (46). In brief, the indicated strains
were grown in YPG to induce Set2 expression, and whole-cell extracts were
prepared. Immunoprecipitations were performed in a final volume of 0.8 ml and
equalized with extraction buffer containing 1.5 mg of whole-cell extract protein.
The extracts were incubated with 4 l of Set2 antibody or 4 l of the matched
preimmune serum for 2 h at 4°C, after which each sample was incubated for 1 h
with 15 l protein A-Sepharose beads (GE Healthcare). The beads were then
washed twice for 10 min in extraction buffer, eluted in SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) loading buffer, and incubated at 100°C for 5 min,
and bead-bound proteins were analyzed by immunoblot analysis using antibodies
targeted against the Ser5 phospho-CTD (H14; Covance Inc.) or the Set2 anti-
body.
Preparation of whole-cell or nuclear extracts and immunoblot assays. Cells
were grown in YPD at 30°C to 1.5  107 cells/ml. Extracts were prepared in
duplicate by breaking the cells with glass beads in 8 M urea for 3 min and boiling
in Laemmli buffer. Extracts were separated by SDS-PAGE on 15% gels, trans-
ferred to Bio-Rad nitrocellulose membranes, and incubated with the antibodies
indicated. Interactions were detected using enhanced chemiluminescence (GE
Healthcare or Pierce) and a horseradish peroxidase anti-species secondary an-
tibody. Nuclear extracts were prepared as described previously (17).
Chromatin immunoprecipitation protocol. Chromatin immunoprecipitation
was performed as described elsewhere (30, 31). In summary, ChIP was done
using 50-ml cultures fixed with 1% formaldehyde for 15 min followed by addition
of glycine to 0.25 mM final concentration. Yeast cells were broken using glass
beads on a MagnaLyser (Roche), and fixed chromatin was sheared by sonication
using a bioruptor (Diagenode). Average DNA fragment lengths were 150 to 300
bp. After centrifugation (30 min, 10,000  g, 4°C), the soluble chromatin was
incubated with antibody to the following epitopes: 12 l of H5 (Covance), 10 l
hemagglutinin (HA; Roche), 3 l of Y80 (Santa Cruz), 3 l of Set2, 3 l of
FLAG M2 (Sigma), and 10 l of myc (Sigma) in 1.5-ml siliconized Eppendorf
tubes at 4°C for 15 to 20 h and immunoprecipitated with protein A-Sepharose or
anti-immunoglobulin M–agarose for H5 antibodies for 90 min at room temper-
ature. After washing, the chromatin was eluted from the beads at 65°C for 30
min. Cross-links were reversed by incubation at 65°C for 6 to 20 h and treated
with protease and RNase A. DNA was purified using Qiagen PCR mini-columns
and eluted in 100 l water. IP samples and IP controls (no antibody) were used
undiluted, while input DNA samples were diluted accordingly. Samples were
subject to real-time PCR using a Corbett Rotorgene and Sybr green mix (Sen-
symix; Quantace). Real-time PCR was used to amplify regions corresponding to
those shown at STE11. Data [(IP  no antibody)/total] were expressed as a
percentage of the input. Error bars reflect the standard deviations of the average
signals obtained between different experiments (n 	 2 to 4). Full details of the
procedure are available on request.
HMT assays. Yeast strains containing SET2 expressed from the GAL1 pro-
moter were grown in raffinose to prevent Set2 expression. Whole-cell extracts
were prepared and sonicated as for ChIP, except for the following alteration in
buffer components: 150 mM NaCl, 50 mM Tris pH 9.0, 0.5 mM EDTA, and 10%
glycerol. Histone methyltransferase (HMT) buffers and the expression of recom-
binant Set2 fused to calmodulin binding protein (rSet2) were prepared as de-
scribed previously (16, 42), where the resulting cell lysate was used directly for
the in vitro histone methyltransferase assay. HMT reaction mixtures contained
100 g of sonicated yeast cell extract with HMT buffer, and 50 M S-adenosyl-
methionine (SAM), with or without 2 l of rSet2 lysate. Samples were incubated
for 30 min at 30°C, resolved by SDS-PAGE, and analyzed for H3K36me2 and
H3K36me3 by Western blotting.
RESULTS
The SRI domain of Set2 is not absolutely required for re-
cruitment of Set2 to chromatin. As the SRI domain of Set2
interacts with the phosphorylated CTD of elongating RNAPII,
we proposed that Set2 recruitment via the SRI domain to the
phosphorylated CTD leads to methylation of the chromatin
during transcription (16). Consistent with this, a strain express-
ing a form of Set2 without the SRI domain, Set21-618, lacks
both H3K36me2 and H3K36me3 (Fig. 1A and B) (16). We
show here, however, by using ChIP of FLAG-tagged Set21-618,
that the SRI domain is not essential for the recruitment of Set2
to chromatin (Fig. 1A and D). Levels of protein associated
with STE11 are 50% of those for full-length Set2, and this
decrease does not reflect lower Set21-618 protein levels (Fig.
1B). This suggests that the SRI domain–phospho-CTD inter-
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action is not essential for Set2 recruitment to chromatin. In
addition, there is no further loss of the ChIP signal at STE11
when an additional 357 residues from Set21-618 are removed,
leaving the amino-terminal 261 residues, including the SET
domain, on Set21-261 (Fig. 1A and D).
Residues 1 to 261, including the SET domain, are sufficient
for H3K36me2 by Set2. Although the strain expressing FLAG-
tagged Set21-618 lacks global H3K36me3 and H3K36me2 (Fig.
1A and B) (16), H3K36me2 is present in the strain expressing
the smaller protein, Set21-261-FLAG, from either the endoge-
nous promoter (Fig. 1B) or from the ADH1 promoter (Fig.
1C). The lower global levels of H3K36me2 in strains expressing
Set21-261-FLAG from the endogenous promoter may reflect
reduced recruitment to chromatin, observed at STE11 (Fig.
1D). At this gene, however, the distribution and levels of
H3K36me2 in the strain expressing Set21-261 are similar to the
WT (Fig. 2A). These observations suggest that the region from
residues 262 to 618 has a specific inhibitory function on the
methyltransferase activity associated with residues 1 to 261.
Taken together these data suggest that the Set2 KMTase
H3K36me3 versus H3K36me2 activity may be regulated, that
the SET domain within residues 1 to 261 of Set2 is sufficient
for H3K36me2, and that the SRI domain is not essential for
Set2 recruitment to chromatin. We next investigated
FIG. 1. The amino-terminal 261 residues of Set2, including the SET domain, are sufficient for H3K36me2. (A) Schematic of the three versions
of Set2 analyzed in this work, showing the various domains and their requirement for H3K36me2 and H3K36me3. , WT levels; , moderate
reduction; (), occasionally seen; , not detectable. (B and C) Western blots of whole-cell extracts prepared from the indicated strains cultured
at 30°C and incubated with antibodies against histone H3, H3K36me3, H3K36me2, the 3FLAG epitope, or H3K4me2. (B) Strains engineered to
express full-length Set2-3FLAG, or Set2-3FLAG derivatives containing the indicated regions, from the endogenous locus. (C) Plasmid-borne
full-length Set2, or a truncated derivative, expressed from the ADH1 promoter in a set2 strain. (D) Chromatin immunoprecipitation to detect
Set2-FLAG or derivatives at three positions on STE11, the coding region (CR) of MET16 and telomere 1L (TEL01L) in the strains indicated. Data
are expressed as the percentage of input signal.
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whether H3K36me2 can direct Rpd3S-mediated chromatin
deacetylation at STE11, leading to repression of the cryptic
promoters.
H3K36me2 is sufficient to direct histone deacetylation and
to repress the internal promoters at STE11. Having a strain
capable of dimethylating but not trimethylating H3K36 en-
abled us to ask if H3K36me2 is sufficient to direct Rpd3S-
mediated deacetylation of chromatin at STE11. In the control
strain expressing Set2-FLAG, H3K18ac is observed at the pro-
moter and drops off toward the 3
 region of the gene (Fig. 2B).
This pattern of distribution for H3K18ac is similar to that
observed in microarray analysis of active genes on chromo-
some III (28). In contrast, strains lacking Set2 or expressing
Set21-618-FLAG display high levels of H3K18ac at the pro-
moter and throughout the transcribed region of STE11, con-
sistent with a failure to deacetylate H3K18 toward the 3

region of STE11 (Fig. 2B). In the strain expressing Set21-261-
FLAG, the distribution of H3K18ac resembles the wild-type
strain, although the signal is reproducibly higher at the pro-
moter. This suggests that H3K36me2 is sufficient to direct
deacetylation of histone H3K18 within the coding region of
STE11.
Set2-dependent deacetylation of the chromatin in the tran-
scribed region of STE11 correlates with repression of internal
cryptic promoters, as observed in the strain expressing Set2-
FLAG (Fig. 2C). In the strain expressing Set21-618-FLAG and
the set2 strain, initiation at the internal promoters is ob-
served, consistent with the high levels of H3K18ac at STE11. In
the strain expressing Set21-261-FLAG, by contrast, initiation of
transcription is repressed. This suggests that dimethylation of
H3K36 by Set21-261 is sufficient for chromatin deacetylation
and repression of the internal cryptic promoters at STE11. To
support our observation that H3K36me2 is sufficient to repress
internal cryptic promoters at STE11 and to ask if H3K36me2
and H3K36me3 by Set2 might be under different regulation
and thus require different factors, we examined mutant strains
reported to affect H3K36 methylation, including spt6-1004 (8),
ctk1 (19, 46), a strain expressing a valine substitution at
H3P38 (34), and strains expressing truncations of the CTD on
the large subunit of RNAPII (8).
The integrity of H3P38 and the CTD of RNAPII are required
for optimal H3K36me3 but not H3K36me2. The cis-trans
isomerization of histone H3 proline 38 by the Fpr4 peptidyl
prolyl isomerases influences H3K36me3 (34). The substitution
of valine for proline at position 38 is proposed to fix the histone
H3 tail in the trans (straight) conformation, resulting in a loss
of H3K36me3 (34). This loss of H3K36me3 does not result
from the inability of the H3K36me3 antibody to recognize its
epitope in the H3P38V strain (34). We show here that in a
strain expressing H3P38V, H3K36me2 is present at similar
levels to the WT strain, suggesting that proline 38 is not im-
portant for dimethylation but does influence trimethylation of
H3K36 (Fig. 3A). This suggests that H3P38V is not inherently
inhibitory to Set2 methylation but that trimethylation is more
sensitive to the loss of proline 38 on histone H3 compared to
dimethylation.
In a similar way, strains expressing the RNAPII large sub-
unit Rpb1 with 10 or 11 copies of the CTD, which are just
sufficient for viability, rather than the normal 26 (35), also
show loss of H3K36me3 while H3K36me2 is present, but at
reduced levels compared to WT (Fig. 3B) (8). This reduction is
unlikely to reflect Set2 protein levels but may reflect the slow
growth associated with these strains.
The levels of Set2 protein in the H3P38V strain are also
similar to the WT control, suggesting that the lower levels of
H3K36me3 are unlikely to result from insufficient enzyme (Fig.
3A and C). To test whether increasing the amount of Set2
FIG. 2. H3K26me2 is sufficient for histone deacetylation and re-
pression of internally initiated transcripts at STE11. (A) Chromatin
immunoprecipitation to detect H3K36me2 at three positions on
STE11, the coding region (CR) of MET16, and telomere 1L (TEL01L)
in the strains indicated. Data are presented as a percentage of the
input signal and are shown normalized to the histone H3 signals.
(B) Chromatin immunoprecipitation to detect H3K18ac at three po-
sitions on STE11 and telomere 1L (TEL01L) in the strains indicated.
Data are presented as a percentage of input signal and shown normal-
ized to the histone H3 signals. (C) Northern blots of total RNA
isolated from the indicated strains, hybridized with a probe from the 3

region of STE11 or RDN18 (18S rRNA). The full-length transcript and
the three (1 to 3) short internally initiated transcripts are indicated.
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protein would restore trimethylation of H3K36 in the H3P38V
strain, we introduced the GAL1 promoter in place of the SET2
promoter at the genomic SET2 locus. As this is the only copy
of SET2 in the genome, Set2 protein is only expressed when
the cells are cultured on galactose (YPG) (Fig. 3C, lanes 4 and
6) and no Set2 is produced in these strains when grown in
raffinose (YPR) (Fig. 3C, lanes 3 and 5). Set2 protein is evident
in total protein extracts prepared from the hht2P38V GAL1:
SET2 strain and the HHT2 GAL1:SET2 strain when induced
with galactose (Fig. 3C, lanes 4 and 6), and this is significantly
increased over the levels of Set2 in the equivalent background
expressing SET2 from the endogenous SET2 promoter (Fig.
3C, lanes 1 and 2). We examined the levels of H3K36me2 in
the strains induced in galactose. Levels were similar to the
control strains, suggesting that the increased levels of Set2
protein do not result in an increase in global levels of dimeth-
ylated H3K36. Next we looked at trimethylated H3K36. In this
experiment there was a very low level of H3K36me3 detectable
FIG. 3. Rpb1 CTD- and H3P38-dependent H3K36me3, but not H3K36me2. (A) Western blot of total protein isolated from an hht1-hhf1
hht2-hhf2 strain expressing HHT2-HHF2 or the P38V derivatives from a plasmid (lane 1, wild-type histone H3; lane 2, H3 with a P38V
substitution; lane 3, set2) incubated with the antibodies indicated. Anti-glyceraldehyde-6-phosphate dehydrogenase (G6PDH) acted as a loading
control. (B) Western blot of total protein extracts from strains carrying truncation of the CTD of Rbp1 (33) incubated with the indicated antibodies.
(C) Western blots of total protein extracts from strains expressing SET2 from the GAL1 promoter integrated at the SET2 locus cultured in raffinose
(lanes 3 and 5; YPR off) or galactose (lanes 4 and 6; YPG on) incubated with the indicated antibodies. Lanes 1 and 2 contain extract from the
strains shown in which SET2 is expressed from the endogenous SET2 promoter. (D and E) Northern blots of total RNA isolated from the strains
indicated below, hybridized with a probe from the 3
 region of STE11 or RDN18 (18S rRNA). The full-length transcript and the three (1 to 3) short
internally initiated transcripts are indicated. (D) H3P38V substitution; (E) Rpb1 derivatives.
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in the hht2P38V strain, similar to that described previously
(34) (Fig. 3C, lane 2). The increased levels of Set2 in the
hht2P38V GAL1:SET2 strain results in a small increase in
H3K36me3 levels (Fig. 3C, lane 6); however, this is low com-
pared to the levels in the WT strains, especially when the
loading is taken into account (Fig. 3C, compare lanes 1, 4, and
6). Thus, increased levels of Set2 protein are not sufficient to
restore H3K36me3 to normal levels when H3P38 is replaced
with valine. We conclude that H3P38 influences trimethylation
of H3K36 even when Set2 levels are increased above normal.
We asked if the presence of H3K36me2 in the strains ex-
pressing histone H3 with the valine substitution at P38
(H3P38V) or the Rpb1 CTD truncations was sufficient to re-
press the cryptic internal promoters at STE11. In all four
strains, no internal initiation of transcription was observed at
STE11 (Fig. 3D and E), supporting the idea that H3K36me2 is
sufficient for repression. In addition, these data suggest specific
roles for H3P38 and the CTD of RNAPII in trimethylation of
H3K36.
Spt6 influences Set2 protein levels. A strain expressing the
spt6-1004 allele shows a defect in methylation of H3K36 (8)
(Fig. 4A). The loss of H3K36 methylation can be partly ex-
plained by the low level of Set2 protein present in the spt6-1004
mutant (Fig. 4A, lane 4) compared to the isogenic WT (Fig.
4A, lane 3). Since SET2 mRNA levels are unaffected in the
spt6-1004 strain (see Fig. S1 in the supplemental material), this
may reflect defects in Set2 protein synthesis or stability. We
note that the overall levels of Set2 protein vary in different WT
strain backgrounds (Fig. 4A, lanes 1 and 3, compare BY4741
and FY2181), but this does not appear to influence the levels
of H3K36me3, which on the Western blot assays correlates
with the amount of histone H3 in the extracts, not the levels of
Set2 protein. In addition, we noticed that the effect of the
spt6-1004 allele on Set2 protein levels varied slightly from
experiment to experiment (data not shown). This is similar to
the effect of the spt6-1004 allele on Ctr9 protein levels and may
reflect inherent instability of the Spt6-1004 protein (12).
In order to understand more precisely how Spt6 influences
H3K36 methylation, we restored Set2 protein levels by express-
ing SET2 from the GAL1 promoter in a construct integrated
into the SET2 locus in the WT and spt6-1004 strains (Fig. 4B).
As this is the only copy of SET2 in the genome, Set2 protein is
only expressed when the cells are cultured on galactose (Fig.
4B, lane 3), and no Set2 is produced in these strains when
grown in raffinose (Fig. 4B, lane 2). Set2 protein is evident in
total protein extracts prepared from the spt6-1004 GAL1:SET2
strain when induced with galactose (Fig. 4B, lane 3), and this is
increased over the levels of Set2 in the WT isogenic parental
strain (Fig. 4B, lane 1).
Next we asked whether the increased levels of Set2 protein
facilitate its recruitment to chromatin (Fig. 4C). Although the
global levels of Set2 protein are increased, the amount and
distribution of Set2 on chromatin, assessed by ChIP at STE11,
MET16, and a telomere in the spt6-1004 strain induced with
galactose to express GAL1:SET2, resemble what are observed
in the control WT strain. Importantly, we observed no associ-
ation of Set2 with an inactive gene (MET16) or at telomeres in
this induced strain. This suggests that the Set2 protein is cor-
rectly targeted to chromatin even when expressed from the
GAL1 promoter and that Spt6 is not essential for this.
Spt6 is required for H3K36 trimethylation but not dimeth-
ylation when Set2 protein levels are restored. We next asked if
the association of Set2 with the chromatin of active genes in
the spt6-1004 mutant might be sufficient to restore both di- and
trimethylation at H3K36. In the spt6-1004 GAL1:SET2 strain
induced with galactose, we observed no signal for H3K36me3,
while a robust signal for dimethylated H3K36 was evident at
levels similar to WT (Fig. 4B, lane 3). We conclude that under
conditions when levels of Set2 are restored at or above those
normally observed, Spt6 is required for the ability of Set2 to
effectively trimethylate H3K36.
The C-terminal regions of Spt6, including the SH2 domain,
are not required for H3K36me3 or H3K36me2. Our data sup-
port a role for the CTD of RNAPII in trimethylation of
H3K36. Both yeast and mammalian Spt6 contain a SH2 do-
main. In mammalian Spt6 the SH2 domain interacts with the
serine 2-phosphorylated CTD of RNAPII in vitro (48), but the
SH2 domain of yeast Spt6 protein is not characterized. To test
FIG. 4. Spt6-dependent H3K36me3, but not H3K36me2, when
Set2 protein is restored. (A) Spt6 influences the levels of Set2 protein.
Western blots of total protein extracts from the strains indicated in-
cubated with the antibodies shown. (B) Western blots of total protein
extracts from strains expressing SET2 from the GAL1 promoter inte-
grated at the SET2 locus in the FY2181 background (WT or spt6-1004)
cultured in raffinose (lane 2; YPR off) or galactose (lane 3; YPG on)
incubated with the indicated antibodies. Lane 1 contains extract from
the WT parental background in which SET2 is expressed from the
endogenous SET2 promoter. (C) Chromatin immunoprecipitation to
detect Set2 at three positions on STE11, the coding region of MET16
(CR), and telomere 01L in the strains indicated, cultured at 30°C in
raffinose (YPR off) or galactose (YPG on). Data are expressed as a
percentage of the input signal. Note that the profile for Set2 at STE11
detected using the polyclonal antibodies is different from that with the
FLAG epitope (see Fig. 1D). These differences are reproducible and
have been observed by others using different epitope tags on Set2 (7).
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whether Spt6 might play a role in H3K36 methylation via an
interaction with the CTD, we constructed a strain expressing a
C-terminal truncation of Spt6 lacking 202 residues, including
the SH2 domain (Fig. 5A). This strain shows a marked slow
growth phenotype and a small reduction in H3K36me3 com-
pared to the isogenic parental strain (Fig. 5B, compare lanes 4
and 5). No defect in H3K36me2 was observed (Fig. 5B, com-
pare lanes 4 and 5). This suggests that Spt6 does not influence
H3K36 methylation via its SH2 domain.
To explore directly whether the Set2 protein expressed from
the GAL1 promoter in the spt6-1004 strain is recruited to
RNAPII, we immunoprecipitated Set2 and asked if phosphor-
ylated RNAPII was present in the precipitated material (Fig.
5C). The Set2 protein from the WT and the spt6-1004 strains is
able to pull down equal amounts of phosphorylated RNA
polymerase II. We conclude that, when expressed from the
GAL1 promoter, the Set2 protein is targeted to RNAPII in the
spt6-1004 strain. We also confirmed that the spt6-1004 allele
does not significantly influence phosphorylation of the CTD at
serine 2 or the distribution of RNAPII at STE11 (see Fig. S2 in
the supplemental material). Furthermore, the reduced levels
of Set2 in the spt6-1004 allele are unlikely to result from a
failure to recruit Set2 to the phospho-CTD via the SRI do-
main, as protein levels in the WT and spt6-1004 backgrounds
are not greatly influenced by the presence or absence of the
SRI domain (see Fig. S3 in the supplemental material).
Spt6 is required for trimethylation but not dimethylation of
H3K36 on a chromatin template by recombinant Set2. Spt6 is
known to bind to the globular domains of histone H3 and H4
and regulate H3K36me3 (4). We therefore designed an ex-
periment to test, in vitro, the role of Spt6 in promoting
Set2-dependent methylation of nucleosomes, the preferred
substrate for Set2 (42). Cell lysates containing sonicated chro-
matin from WT and spt6-1004 strains in which SET2 is not
expressed were incubated with recombinant Set2 and SAM for
30 min at 30°C (Fig. 5D). These reactions were analyzed by
Western blotting using antibodies against H3K36me3 and
H3K36me2. Antibodies against H3 and Set2 were used as a
loading control or to verify the presence of rSet2, respectively.
We observed a significant reduction in the ability of recombi-
nant Set2 to trimethylate chromatin obtained from the spt6-
1004 strain compared to the WT strain (Fig. 5D, compare lanes
2 and 3). However, equivalent signals for H3K36me2 were
obtained in extracts from both strains. A negligible level of
FIG. 5. Spt6 influences the ability of Set2 to trimethylate chromatin in vitro but does not influence Set2 association with RNAPII. (A) Sche-
matic of Spt6 showing the regions missing in the two derivatives. spt6-1004-FLAG is in the FY2181 background in which the WT Spt6 is also FLAG
tagged, and Spt6C is in the FY118 background in which a stop codon and the ADH1 terminator has replaced the SPT6 sequences at positions
1250 (Spt6C) or 1452 (WT). (B) Western blots of total protein extracts from the indicated strains incubated with the antibodies indicated. Strains
were cultured at 30°C, the permissive growth temperature for spt6-1004. (C) Extracts from strains expressing FLAG-tagged Spt6 (WT FY2181)
or Spt6-1004 were immunoprecipitated (IP) with anti-Set2 antibodies (lanes 1 and 2) or preimmune serum (lanes 3 and 4), and association with
Ser5 P-CTD was assessed using H14 antibodies by Western blotting. Levels of Set2 in the IP were monitored to assess recovery. (D) Spt6 controls
trimethylation of H3K36 by recombinant Set2. WT and spt6-1004 strains, with GAL1:SET2 at the SET2 locus, were grown in YPR (raffinose) to
ensure repression of SET2 under the GAL1 promoter. Equal amounts of sonicated whole-cell extract were used in a HMT reaction in which the
sonicated extracts were incubated with 50 M SAM (all lanes) and with (lanes 2 and 3) or without (lanes 1 and 4) an equal amount of purified
recombinant Set2 (rSet2) (16) at 30°C for 30 min. Aliquots of the reaction mixture were analyzed by Western blotting using antibodies raised
against Set2, H3K36me2, H3K36me3, and histone H3. Due to the challenges in the use of the H3K36me2 antibody as described previously (17),
representative blots from more than three experiments are shown. In each case, the independent replicates yielded equivalent results. Note that
no H3K36me3 or H3K36me2 was detected without the addition of rSet2, despite the presence of SAM.
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H3K36me2 and H3K36me3 was present in either strain back-
ground in the absence of rSet2, despite the addition of SAM.
This result recapitulates the data in vivo and suggests that the
chromatin in the spt6-1004 strain is a poor substrate for tri-
methylation of H3K36 by Set2.
Ctk1 influences the levels of Set2 protein. Ctk1 is a kinase
that phosphorylates the CTD of Rbp1. Unlike the strains ex-
pressing CTD truncations, the ctk1 strain affects dimethyla-
tion and trimethylation at lysine 36 (8, 19, 46), suggesting
additional functions for Ctk1 in Set2 function. To resolve this,
we examined the levels of Set2 protein and its recruitment to
STE11 in the ctk1 strain. We observe reduced levels of Set2
in the ctk1 strain (Fig. 6A). Since SET2 mRNA levels are
unaffected in this strain (46), the loss of H3K36 methylation is
likely to be due to a reduction in Set2 protein synthesis, con-
sistent with a role for Ctk1 in translation elongation (40) or a
problem with the stability of Set2 (2).
In order to understand more precisely how Ctk1 influences
H3K36 methylation, we restored Set2 protein levels by express-
ing SET2 from the GAL1 promoter in a construct integrated
into the SET2 locus in the WT and ctk1 strain (Fig. 6B). Set2
is not expressed when the cells are cultured on raffinose (Fig.
6B, lanes 2 and 5). Set2 protein is evident in total protein
extracts prepared from the WT and ctk1 GAL1:SET2 strains
when induced with galactose (Fig. 6B, lanes 3 and 6), and these
are all increased over the levels of Set2 in the WT isogenic
parental strains (Fig. 6B, lanes 1 and 4).
Next we asked whether the increased levels of Set2 protein
FIG. 6. Ctk1 is required for H3K36me3 but not H3K36me2 when Set2 levels are restored. (A) Ctk1 influences the levels of Set2 protein.
Western blot results shown are of total protein extracts from the strains indicated incubated with antibodies indicated. In this and subsequent
experiments set2 and ctk1 are in the BY4741 background, the Euroscarf reference strain. (B) Western blots of total protein extracts from strains
expressing SET2 from the GAL1 promoter in the BY4741 background (left panel) or the same background with ctk1 (right panel) cultured in
raffinose (YPR off) or galactose (YPG on) incubated with the antibodies indicated. Lanes 1 and 4 contain extracts from the WT parental
backgrounds in which SET2 is expressed from the endogenous promoter. (C) Chromatin immunoprecipitation to detect Set2 at three positions on
STE11, the coding region of MET16 (CR), and telomere 01L in the strains indicated, cultured at 30°C in raffinose (YPR off) or galactose (YPG
on). Data are expressed as a percentage of input signal. Note that the profile for Set2 at STE11 detected using the polyclonal antibodies is different
from that with the FLAG epitope (see Fig. 1D). These differences are reproducible and have been observed by others using different epitope tags
on Set2 (7).
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facilitate its recruitment to chromatin (Fig. 6C). The amount
and distribution of Set2 on chromatin, assessed by ChIP at
STE11, MET16, and a telomere, in the WT strain and the
ctk1 strain cultured in galactose to induce SET2 expression
from the GAL1 promoter resemble those in the control WT
strain (Fig. 6C). Importantly, we observed no association of
Set2 with an inactive gene (MET16) or at telomeres in these
induced strains. This suggests that the Set2 protein was cor-
rectly targeted to chromatin in this experiment and that Ctk1 is
not essential for this.
Ctk1 is required for H3K36 trimethylation but not dimeth-
ylation when Set2 protein levels are restored. Given the ability
to restore Set2 levels in the ctk1 strain, we next asked if the
association of Set2 with the chromatin of active genes in this
mutant might be sufficient to restore both di- and trimethyl-
ation at H3K36. In the WT strain expressing GAL1:SET2, the
increased Set2 levels lead to a small decrease in global
H3K36me2 and no change in H3K36me3 (Fig. 4B, compare
lanes 1 and 3). We observed only a trace signal for H3K36me3
in the ctk1 strain (Fig. 6B, lane 6). However, a robust signal
for dimethylated H3K36 was evident at levels similar to WT
(Fig. 6B, compare lanes 4 and 6). We conclude that under
conditions when Set2 proteins levels are restored at or above
those normally observed, Ctk1 is required for Set2 to effec-
tively trimethylate H3K36. Taken together these data implicate
Ctk1, the phosphorylated CTD of RNAPII, and the C-terminal
domain of Set2 in trimethylation but not dimethylation of
H3K36.
Both Ctk1 and Spt6 are important for H3K36me2 mainte-
nance, but only Ctk1 has a role in repression of the cryptic
promoters at STE11. We have shown that dimethylation of
H3K36 by Set21-261 is sufficient for chromatin deacetylation
and repression of the cryptic promoters at STE11. Next we
asked if dimethylation of H3K36 in the spt6-1004 GAL1:SET2
and ctk1 GAL1:SET2 strains induced with galactose is suffi-
cient for repression of cryptic promoters at STE11. This might
indicate additional functions for Spt6 and Ctk1 beyond
H3K36me2.
The presence of H3K36me2 in the induced spt6-1004 GAL-
SET2 strain was correlated with efficient repression of the
cryptic promoters at STE11 (Fig. 7A, lane 6). This suggests that
Spt6 plays no direct role in repression of cryptic internal
promoters at STE11 other than maintaining H3K36me2. By
contrast, in the ctk1 GAL1-SET2 strain, restoration of
H3K36me2 was not sufficient to repress the cryptic promoters
(Fig. 7A, lane 8). We propose that Ctk1 may have an additional
function, independent of Set2, in repression of cryptic initia-
tion at STE11.
Spt6 represses internal initiation at FLO8 independently of
H3K36me2. Genes such as FLO8 also show a low level of
internal initiation of transcription in strains lacking H3K36
methylation (Fig. 7B, lanes 3 and 5) (5). Spt6 is required to
repress cryptic initiation at FLO8 (Fig. 7B, lanes 2, 7, and 9) (5,
13). The effect of loss of H3K36 methylation or Spt6 on the
amount of internally initiated transcript is enhanced by heat
shock (Fig. 7B, lanes 2, 5, and 9, compared to lanes 3 and 7).
The low levels of internal initiation that occur when Set2 is
absent are repressed when SET2 is expressed from the GAL1
promoter (Fig. 7B, lanes 4 and 6). We asked if restoration of
Set2 protein levels in the spt6-1004 strain would repress inter-
nal initiation at FLO8, as observed at STE11 (Fig. 7A). No
repression was observed in either RNA prepared from yeast
grown at 30°C (Fig. 7B, lane 8 [same RNA samples as analyzed
in A]) or after a heat shock at 39°C (Fig. 7B, lane 10). We
FIG. 7. H3K36me2 is sufficient to repress the cryptic promoters at
STE11 and FLO8. Northern blots show total RNA isolated from the
WT, spt6-1004, and ctk1 strains expressing SET2 from the GAL1
promoter induced with galactose (YPG on) or repressed with raffinose
(YPR off), hybridized with a probe from the 3
 region of STE11 (A) or
FLO8 (B). RDN18 (18S rRNA) acted as a loading control. For the
experiment shown in panel B, WT and spt6-1004 strains were heat
shocked at 39°C for 60 min to inactive Spt6-1004 function. The full-
length transcript and short internally initiated transcripts at each gene
are indicated.
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conclude that Spt6 represses internal initiation at FLO8 by a
mechanism that is distinct from H3K36me2-mediated histone
deacetylation.
DISCUSSION
The current view of methylation of H3K36 is that it is tightly
linked to the elongation phase of transcription through the
recruitment of Set2 via the SRI domain to the CTD of RNAPII
when phosphorylated at serine 2 by Ctk1. In this scenario,
deletion of either CTK1 or the region encoding the SRI do-
main on SET2 leads to loss of Set2-RNAPII association which,
in turn, results in a loss of H3K36 dimethylation and trimeth-
ylation, a failure to deacetylate transcribed chromatin, and
internal initiation of transcription within genes such as STE11.
Here we showed that only trimethylation of H3K36 is linked to
the elongating form of RNAPII. H3K36me3 requires the C-
terminal region of Set2, including the SRI domain, and is
dependent on the CTD of RNAPII, the Ctk1 kinase, the in-
tegrity of proline 38 on histone H3, and the transcription elon-
gation factor Spt6. In contrast, these factors are not required
for dimethylation of H3K36. Moreover, the N-terminal do-
main of Set2, containing the SET domain, is sufficient for
H3K36me2. The discrepancies between our data and the pre-
viously published data can be resolved (8, 16, 19, 46). First,
mutant strains such as ctk1 and spt6-1004 may only show loss
of H3K36 dimethylation because levels of Set2 protein are
decreased. Set2 protein has a short half-life (S. Fuchs and B.
Strahl, unpublished data) (2). In addition, Ctk1 is required for
efficient translation elongation in yeast (40). Together these
can explain the reduced levels of Set2 protein in the ctk1
strain. A possible explanation for how Spt6 influences Set2
function might have been provided if Spt6 could directly asso-
ciate with, and thereby stabilize, Set2. However, we detected
no interaction between Spt6 and Set2 using conventional co-
immunoprecipitation experiments (data not shown). There-
fore, the ability of Spt6 to regulate Set2 protein levels is likely
due to a downstream effect of the HhH domain and its func-
tion on transcribed genes. Reduced levels of other proteins,
such as Ctr9, have also been observed in the spt6-1004 strain
(12), suggesting that the effect is not specific to Set2. We also
ruled out a role for Spt6 in recruiting or stabilizing the inter-
action between Set2 and chromatin, as recruitment of Set2 to
chromatin in the spt6-1004 mutant can be restored by overex-
pression of SET2.
The second discrepancy concerns the role of the SRI domain
(16). Our data suggest that an interaction between the CTD
and the SRI domain is necessary for trimethylation of H3K36
in the context of the full-length Set2 protein. However, we
previously showed that strains expressing a version of Set2
lacking the C-terminal SRI domain lose both H3K36me2 and
H3K36me3. We suggest that the sequences between the N-
terminal AWS-SET-PS domain and the C-terminal SRI do-
main may inhibit the activity of the SET domain (especially in
the absence of the SRI domain), raising the possibility that
Set2 activity is regulated. In this model, the middle region of
the WT protein represses Set2 trimethylation activity, and re-
pression is relieved by the SRI interaction with the CTD.
Further work is necessary to confirm this. However, our data
support tight control over Set2 function. We propose that
without the internal conformation changes to Set2, correct
recruitment, and an appropriate nucleosomal substrate, Set2
may become unstable or degraded in a regulated way, limiting
Set2 action to properly configured nucleosomes. Furthermore,
our studies point to the ability of Set2 to recognize and meth-
ylate H3 in a context that is CTD independent; however, CTD
binding is likely required for optimal or full catalytic activity.
As a result of having strains that lack H3K36me3, we have
been able to demonstrate that H3K36me2 is sufficient for his-
tone deacetylation and repression of the cryptic promoters at
STE11. This is consistent with the observation that the chro-
modomain of Eaf3, a component of the Rpd3S histone
deacetylase complex, forms a specific interaction with nucleo-
somes or peptides dimethylated at H3K36 (5, 23). This result
suggests another function for H3K36me3 in the transcription
process that remains to be defined. We have been unable to
show any role for H3K36me3 in functions associated with
the expression of telomere proximal genes (43) (K. Kizer,
unpublished data) or the PAF1 complex (M. Youdell, un-
published data). For example, Paf1-dependent poly(A) site
usage at MAK21 (37) is not affected in the Set21-261 strain,
although paf1 strains do show reduced levels of Set2 pro-
tein. Although we have been unable to define a specific
function for H3K36me3, we have defined other factors that
are specific to H3K36me3 but not H3K36me2, including the
integrity of proline 38 on histone H3 and Spt6.
Proline 38 is reported to undergo cis (bent) to trans
(straight) isomerization by Fpr4, a putative peptidyl-prolyl
isomerase for H3P38 (34). This change is expected to have a
major influence on the local structure of the histone H3 N-
terminal tail in the nucleosome. In their paper, Kouzarides and
coworkers proposed that cis-proline 38 would facilitate meth-
ylation at K36 in the deep cleft at the active site of Set2. Our
data suggest that this cannot be the case for H3K36me2, as this
is independent of H3P38. However, trimethylation by Set2 is
influenced by H3P38. Whether this reflects cis-trans isomeriza-
tion of P38 is unknown; however, it is clear that the local
environment on histone H3 is important for the establishment
of H3K36me states.
Our data also suggest that the role for Spt6 in trimethylation
of K36 may be related to the chromatin template rather than
recruitment of Set2 to RNAPII. Sonicated whole-cell lysates
containing fragmented chromatin from WT cells support di-
and trimethylation by recombinant Set2, while chromatin from
a spt6-1004 strain is only capable of supporting dimethylation.
These experiments suggest an Spt6-dependent defect in the
chromatin structure that specifically prevents trimethylation.
However, we cannot rule out the possibility that Spt6 controls
the expression of an as-yet-unknown cofactor that could be
required for H3K36me3 by Set2. Future studies using purified
chromatin may be able to elucidate these questions. Despite
our attempts to do this, we were unable to produce a system
where H3K36me3 directed by recombinant Set2 was possible,
even from a WT extract. As we are unable to demonstrate
experimentally a direct link between Fpr4 and Spt6 (Youdell,
unpublished), it is unlikely that Spt6 influences P38 directly.
Instead, a role for Spt6 in maintaining a chromatin structure
suitable for trimethylation fits very well with its proposed func-
tion as an H3/H4 chaperone during transcription elongation.
We cannot, however, rule out roles for Spt6 in creating nu-
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cleosomal accessibility through an interaction with DNA or
antagonizing a chromatin-associated repressor of H3K36me3.
It is clear that from this work that Spt6 does not play a direct
role in repressing transcription initiation from the H3K36
methylation-sensitive cryptic promoters at STE11, but rather it
is an indirect role, with Spt6 maintaining Set2 protein levels.
Once Set2 protein levels are restored, initiation from the cryp-
tic promoter at STE11 is repressed, correlating with the resto-
ration of H3K36me2 in the spt6-1004 background. Based on
this, and the absence of transcripts initiated from the cryptic
promoter at STE11 in other strains that also have H3K36me2
but not K36me3, we suggest that dimethylation is sufficient for
repression at STE11. This is entirely consistent with genome-
wide data showing that H3K36me2 correlates with gene ex-
pression but not with transcription frequency (39). Moreover,
the CTD phosphorylation independence of H3K36me2 is con-
sistent with its establishment during the initial phases of gene
activation (31), with subsequent transcription having only a
maintenance role.
Longer genes and infrequently transcribed genes tend to be
more dependent on the Set2/Rpd3S deacetylation pathway for
accurate transcription and repression of internally initiated
transcripts (23). FLO8 falls into this category and shows low
levels of internal initiation in the absence of Set2 that are
repressed when SET2 is expressed. A key question is whether
the Set2/Rpd3S pathway is the only mechanism to maintain
accurate transcription at this group of genes. At FLO8,
H3K36me2 is not sufficient to repress internal initiation in the
spt6-1004 mutant, raising the possibility that at this gene
H3K36me3 is required or that Spt6 has an additional function
unrelated to H3K36 methylation. No internal initiation is ob-
served at FLO8 in the H3P38V strains or the CTD truncations
which lack H3K36me3, leading us to conclude that there is a
distinct mechanism by which Spt6 functions at FLO8.
In contrast to Spt6, Ctk1 does play a role in repressing the
cryptic promoters at STE11, even when H3K36me2 has been
restored by Set2 overexpression. This may reflect additional
activities associated with Ctk1, for example, its role in limiting
H3K4me3 to the 5
 regions of genes, which is independent of
its role in maintaining H3K36 methylation (47). Given that
H3K4me3 is associated with histone acetylation and unstable
chromatin at the 5
 region of genes, the presence of trimethyl-
ated K4 toward the 3
 region of open reading frames, together
with loss of other Ctk1 functions, may be sufficient to permit
transcription from the cryptic promoter even in the presence of
H3K36me2. We note that other mutant strains, such as spt16-
197, behave like the ctk1 strain and fail to repress the internal
initiation at STE11, even in the presence of H3K36me2 (8)
(data not shown). This strain carries a conditional mutation in
SPT16, encoding a putative chaperone function for H2A/H2B
during transcription elongation with an additional role in tran-
scription initiation at promoters (3, 8). We suggest that these
factors will have additional functions in the repression of tran-
scription initiation at STE11.
Our data strongly support a role for H3K36me2 in creating
a repressive chromatin environment on genes that are acti-
vated for transcription, as proposed previously (8, 15). Here we
show that this is critical to maintain the correct usage of RNA
initiation sites. The strains used here that lack H3K36me3, but
with H3K36me2, show a slow growth rate, as observed for
strains lacking the Bur1/2 kinase that also lack H3K36me3 (7,
8, 15). Slow growth can be overcome by deletion of SET2,
supporting the idea that H3K36me2 is a repressive mark (15).
In the cell, cotranscription of H3K36me3 would be required to
overcome this repression. Our data define a range of condi-
tions that, in addition to the Bur1/2 kinase, are required for the
transition from H3K36me2 to H3K36me3 and relief from the
repressive chromatin environment. This complex dynamic
would ensure that a gene is efficiently expressed while main-
taining the integrity of the chromatin and transcription initia-
tion.
ACKNOWLEDGMENTS
We thank Anitha Nair for excellent technical support, Fred Win-
ston, Greg Prelich, and Karen Arndt for strains and advice during the
course of this work, Alexandre Akoulitchev, Laurent Kuras, and Do-
minico Libri for comments on the manuscript, and all members of the
laboratories for their support during this work.
This work was funded by grants to J.M. from The Wellcome Trust,
BBSRC, and CRUK and by a grant to B.D.S. from the National
Institutes of Health. M.Y. holds a BBSRC studentship. B.D.S. is a Pew
Scholar in the Biomedical Sciences.
REFERENCES
1. Adkins, M. W., and J. K. Tyler. 2006. Transcriptional activators are dispens-
able for transcription in the absence of spt6-mediated chromatin reassembly
of promoter regions. Mol. Cell 21:405–416.
2. Belle, A., A. Tanay, L. Bitincka, R. Shamir, and E. K. O’Shea. 2006. Quan-
tification of protein half-lives in the budding yeast proteome. Proc. Natl.
Acad. Sci. USA 103:13004–13009.
3. Biswas, D., R. Dutta-Biswas, D. Mitra, Y. Shibata, B. D. Strahl, T. Formosa,
and D. J. Stillman. 2006. Opposing roles for Set2 and yFACT in regulating
TBP binding at promoters. EMBO J. 25:4479–4489.
4. Bortvin, A., and F. Winston. 1996. Evidence that Spt6p controls chromatin
structure by a direct interaction with histones. Science 272:1473–1476.
5. Carrozza, M. J., B. Li, L. Florens, T. Suganuma, S. K. Swanson, K. K. Lee,
W. J. Shia, S. Anderson, J. Yates, M. P. Washburn, and J. L. Workman.
2005. Histone H3 methylation by Set2 directs deacetylation of coding regions
by Rpd3S to suppress spurious intragenic transcription. Cell 123:581–592.
6. Cho, E. J., M. S. Kobor, M. Kim, J. Greenblatt, and S. Buratowski. 2001.
Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA
polymerase II C-terminal domain. Genes Dev. 15:3319–3329.
7. Chu, Y., R. Simic, M. H. Warner, K. M. Arndt, and G. Prelich. 2007.
Regulation of histone modification and cryptic transcription by the Bur1 and
Paf1 complexes. EMBO J. 26:4646–4656.
8. Chu, Y., A. Sutton, R. Sternglanz, and G. Prelich. 2006. The BUR1 cyclin-
dependent protein kinase is required for the normal pattern of histone
methylation by SET2. Mol. Cell. Biol. 26:3029–3038.
9. Clark-Adams, C. D., and F. Winston. 1987. The SPT6 gene is essential for
growth and is required for delta-mediated transcription in Saccharomyces
cerevisiae. Mol. Cell. Biol. 7:679–686.
10. Hartzog, G. A., T. Wada, H. Handa, and F. Winston. 1998. Evidence that
Spt4, Spt5 and Spt6 control transcription elongation by RNA polymerase II.
Genes Dev. 12:357–369.
11. Joshi, A. A., and K. Struhl. 2005. Eaf3 chromodomain interaction with
methylated H3-K36 links histone deacetylation to Pol II elongation. Mol.
Cell 20:971–978.
12. Kaplan, C. D., M. J. Holland, and F. Winston. 2005. Interaction between
transcription elongation factors and mRNA 3
-end formation at the Saccha-
romyces cerevisiae GAL10-GAL7 locus. J. Biol. Chem. 280:913–922.
13. Kaplan, C. D., L. Laprade, and F. Winston. 2003. Transcription elongation
factors repress transcription initiation from cryptic sites. Science 301:1096–
1099.
14. Kaplan, C. D., J. R. Morris, C.-T. Wu, and F. Winston. 2000. Spt5 and Spt6
are associated with active transcription and have characteristics of general
elongation factors in D. melanogaster. Genes Dev. 14:2623–2634.
15. Keogh, M. C., S. K. Kurdistani, S. A. Morris, S. H. Ahn, V. Podolny, S. R.
Collins, M. Schuldiner, K. Chin, T. Punna, N. J. Thompson, C. Boone, A.
Emili, J. S. Weissman, T. R. Hughes, B. D. Strahl, M. Grunstein, J. F.
Greenblatt, S. Buratowski, and N. J. Krogan. 2005. Cotranscriptional set2
methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell
123:593–605.
16. Kizer, K. O., H. P. Phatnani, Y. Shibata, H. Hall, A. L. Greenleaf, and B. D.
Strahl. 2005. A novel domain in Set2 mediates RNA polymerase II interac-
tion and couples histone H3 K36 methylation with transcript elongation.
Mol. Cell. Biol. 25:3305–3316.
VOL. 28, 2008 REGULATION OF H3K36 METHYLATION BY Spt6 AND Ctk1 4925
17. Kizer, K. O., T. Xiao, and B. D. Strahl. 2006. Accelerated nuclei preparation
and methods for analysis of histone modifications in yeast. Methods 40:296–
302.
18. Krogan, N. J., M. Kim, S. H. Ahn, G. Zhong, M. S. Kobor, G. Cagney, A.
Emili, A. Shilatifard, S. Buratowski, and J. F. Greenblatt. 2002. RNA poly-
merase II elongation factors of Saccharomyces cerevisiae: a targeted pro-
teomics approach. Mol. Cell. Biol. 22:6979–6992.
19. Krogan, N. J., M. Kim, A. Tong, A. Golshani, G. Cagney, V. Canadien, D. P.
Richards, B. K. Beattie, A. Emili, C. Boone, A. Shilatifard, S. Buratowski,
and J. Greenblatt. 2003. Methylation of histone H3 by Set2 in Saccharomyces
cerevisiae is linked to transcriptional elongation by RNA polymerase II. Mol.
Cell. Biol. 23:4207–4218.
20. Landry, J., A. Sutton, T. Hesman, J. Min, R.-M. Xu, M. Johnston, and R.
Sternglanz. 2003. Set2-catalyzed methylation of histone H3 represses basal
expression of GAL4 in Saccharomyces cerevisiae. Mol. Cell. Biol. 23:5972–
5978.
21. Lee, J. M., and A. L. Greenleaf. 1991. CTD kinase large subunit is encoded
by CTK1, a gene required for normal growth of Saccharomyces cerevisiae.
Gene Expr. 1:149–167.
22. Li, B., M. Gogol, M. Carey, D. Lee, C. Seidel, and J. L. Workman. 2007.
Combined action of PHD and chromo domains directs the Rpd3S HDAC to
transcribed chromatin. Science 316:1050–1054.
23. Li, B., M. Gogol, M. Carey, S. G. Pattenden, C. Seidel, and J. L. Workman.
2007. Infrequently transcribed long genes depend on the Set2/Rpd3S path-
way for accurate transcription. Genes Dev. 21:1422–1430.
24. Li, B., L. Howe, S. Anderson, J. R. Yates III, and J. L. Workman. 2003. The
Set2 histone methyltransferase functions through the phosphorylated car-
boxyl-terminal domain of RNA polymerase II. J. Biol. Chem. 278:8897–8903.
25. Li, J., D. Moazed, and S. P. Gygi. 2002. Association of the histone methyl-
transferase Set2 with RNA polymerase II plays a role in transcription elon-
gation. J. Biol. Chem. 277:49383–49388.
26. Li, M., H. P. Phatnani, Z. Guan, H. Sage, A. L. Greenleaf, and P. Zhou. 2005.
Solution structure of the Set2-Rpb1 interacting domain of human Set2 and
its interaction with the hyperphosphorylated C-terminal domain of Rpb1.
Proc. Natl. Acad. Sci. USA 102:17636–17641.
27. Lindstrom, D. L., S. L. Squazzo, N. Muster, T. A. Burckin, K. C. Wachter,
C. A. Emigh, J. A. McCleery, J. R. Yates IIII, and G. A. Hartzog. 2003. Dual
roles for Spt5 in pre-mRNA processing and transcription elongation re-
vealed by identification of Spt5-associated proteins. Mol. Cell. Biol. 23:1368–
1378.
28. Liu, C. L., T. Kaplan, M. Kim, S. Buratowski, S. L. Schreiber, N. Friedman,
and O. J. Rando. 2005. Single-nucleosome mapping of histone modifications
in S. cerevisiae. PLoS Biol. 3:e28.
29. Longtine, M. S., A. McKenzie, D. J. Demarini, N. G. Shah, A. Wach, A.
Brachat, P. Philippsen, and J. R. Pringle. 1998. Additional modules for
versatile and economical PCR-based gene deletion and modification in Sac-
charomyces cerevisiae. Yeast 14:953–961.
30. Meluh, P. D., and J. R. Broach. 1999. Immunological analysis of yeast
chromatin. Methods Enzymol. 304:414–430.
31. Morillon, A., N. Karabetsou, A. Nair, and J. Mellor. 2005. Dynamic lysine
methylation on histone H3 defines the regulatory phase of gene transcrip-
tion. Mol. Cell 18:723–734.
32. Mumberg, D., R. Muller, and M. Funk. 1995. Yeast vectors for the con-
trolled expression of heterologous proteins in different genetic backgrounds.
Gene 156:119–122.
33. Murray, S., R. Udupa, S. Yao, G. A. Hartzog, and G. Prelich. 2001. Phos-
phorylation of the RNA polymerase II carboxy-terminal domain by the Bur1
cyclin dependent kinase. Mol. Cell. Biol. 21:4089–4096.
34. Nelson, C. J., H. Santos-Rosa, and T. Kouzarides. 2006. Proline isomeriza-
tion of histone H3 regulates lysine methylation and gene expression. Cell
126:905–916.
35. Nonet, M., D. Sweetser, and R. A. Young. 1987. Functional redundancy and
structural polymorphism in the large subunit of RNA polymerase II. Cell
50:909–915.
36. Patturajan, M., N. K. Conrad, D. B. Bregman, and J. L. Corden. 1999. Yeast
carboxyl-terminal domain kinase I positively and negatively regulates RNA
polymerase II carboxyl-terminal domain phosphorylation. J. Biol. Chem.
274:27823–27828.
37. Penheiter, K. L., T. M. Washburn, S. E. Porter, M. G. Hoffman, and J. A.
Jaehning. 2005. A posttranscriptional role for the yeast Paf1-RNA polymer-
ase II complex is revealed by identification of primary targets. Mol. Cell
20:213–223.
38. Pokholok, D. K., C. T. Harbison, S. Levine, M. Cole, N. M. Hannett, T. I.
Lee, G. W. Bell, K. Walker, P. A. Rolfe, E. Herbolsheimer, J. Zeitlinger, F.
Lewitter, D. K. Gifford, and R. A. Young. 2005. Genome-wide map of nu-
cleosome acetylation and methylation in yeast. Cell 122:517–527.
39. Rao, B., Y. Shibata, B. D. Strahl, and J. D. Lieb. 2005. Dimethylation of
histone H3 at lysine 36 demarcates regulatory and nonregulatory chromatin
genome-wide. Mol. Cell. Biol. 25:9447–9459.
40. Rother, S., and K. Strasser. 2007. The RNA polymerase II CTD kinase Ctk1
functions in translation elongation. Genes Dev. 21:1409–1421.
41. Schaft, D., A. Roguev, K. M. Kotovic, A. Shevchenko, M. Sarov, A.
Shevchenko, K. M. Neugebauer, and A. F. Stewart. 2003. The histone 3 lysine
36 methyltransferase, SET2, is involved in transcriptional elongation. Nu-
cleic Acids Res. 31:2475–2482.
42. Strahl, B. D., P. A. Grant, S. D. Briggs, Z. W. Sun, J. R. Bone, J. A. Caldwell,
S. Mollah, R. G. Cook, J. Shabanowitz, D. F. Hunt, and C. D. Allis. 2002.
Set2 is a nucleosomal histone H3-selective methyltransferase that mediates
transcriptional repression. Mol. Cell. Biol. 22:1298–1306.
43. Tompa, R., and H. D. Madhani. 2007. Histone H3 lysine 36 methylation
antagonizes silencing in Saccharomyces cerevisiae independently of the
Rpd3S histone deacetylase complex. Genetics 175:585–593.
44. Tripic, T., D. G. Edmondson, J. K. Davie, B. D. Strahl, and S. Y. Dent. 2006.
The Set2 methyltransferase associates with Ssn6 yet Tup1-Ssn6 repression is
independent of histone methylation. Biochem. Biophys. Res. Commun. 339:
905–914.
45. Vojnic, E., B. Simon, B. D. Strahl, M. Sattler, and P. Cramer. 2006. Structure
and carboxyl-terminal domain (CTD) binding of the Set2 SRI domain that
couples histone H3 Lys36 methylation to transcription. J. Biol. Chem. 281:
13–15.
46. Xiao, T., H. Hall, K. O. Kizer, Y. Shibata, M. C. Hall, C. H. Borchers, and
B. D. Strahl. 2003. Phosphorylation of RNA polymerase II CTD regulates
H3 methylation in yeast. Genes Dev. 17:654–663.
47. Xiao, T., Y. Shibata, B. Rao, R. N. Laribee, R. O’Rourke, M. J. Buck, J. F.
Greenblatt, N. J. Krogan, J. D. Lieb, and B. D. Strahl. 2007. The RNA
polymerase II kinase Ctk1 regulates positioning of a 5
 histone methylation
boundary along genes. Mol. Cell. Biol. 27:721–731.
48. Yoh, S. M., H. Cho, L. Pickle, R. M. Evans, and K. A. Jones. 2007. The Spt6
SH2 domain binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing
and export. Genes Dev. 21:160–174.
49. Zhang, W., J. R. Bone, D. G. Edmondson, B. M. Turner, and S. Y. Roth.
1998. Essential and redundant functions of histone acetylation revealed by
mutation of target lysines and loss of the Gcn5p acetyltransferase. EMBO J.
17:3155–3167.
4926 YOUDELL ET AL. MOL. CELL. BIOL.
